S100A9 induces monocyte/ macrophage migration via EMMPRIN.
Dr. V. I. Alexaki, Department of Clinical Pathobiochemistry, Fetscherstrasse 74, 01307 Dresden, Germany, Tel.: +49 351 458 16273, E-mail: Ismini.Alexaki@uniklinikum-dresden.de.
Vasileia Ismini
VI
Alexaki
Andreas E
AE
May
Chika
C
Fujii
Saskia N I
SN
V Ungern-Sternberg
Christine
C
Mund
Meinrad
M
Gawaz
Triantafyllos
T
Chavakis
Peter
P
Seizer
D000818:Animals; D051926:Basigin / Q000187:drug effects* / Q000378:metabolism; D040502:Calgranulin B / Q000494:pharmacology*; D002465:Cell Movement / Q000187:drug effects*; D002478:Cells, Cultured; D048049:Extracellular Signal-Regulated MAP Kinases / Q000378:metabolism; D006801:Humans; D008262:Macrophage Activation / Q000187:drug effects*; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D009000:Monocytes / Q000187:drug effects* / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects
C497886:BSG protein, human; C497887:Bsg protein, mouse; D040502:Calgranulin B; D051926:Basigin; D051057:Proto-Oncogene Proteins c-akt; D048049:Extracellular Signal-Regulated MAP Kinases